Search Results - "Koenig, Wolfgang"

Refine Results
  1. 1

    High-sensitivity C-reactive protein and atherosclerotic disease: From improved risk prediction to risk-guided therapy by Koenig, Wolfgang

    Published in International journal of cardiology (15-10-2013)
    “…Abstract There is compelling experimental and clinical evidence suggesting a crucial role for inflammation in the initiation and also the progression of…”
    Get full text
    Journal Article
  2. 2

    Biomarkers of Atherosclerotic Plaque Instability and Rupture by Koenig, Wolfgang, Khuseyinova, Natalie

    “…Basic research over the last two decades has identified a large number of molecules pertinent to the atherosclerotic process, which have clearly improved our…”
    Get full text
    Journal Article
  3. 3

    Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia by Raal, Frederick J, Kallend, David, Ray, Kausik K, Turner, Traci, Koenig, Wolfgang, Wright, R. Scott, Wijngaard, Peter L.J, Curcio, Danielle, Jaros, Mark J, Leiter, Lawrence A, Kastelein, John J.P

    Published in The New England journal of medicine (16-04-2020)
    “…This phase 3 trial evaluated the safety and efficacy of inclisiran, a small interfering RNA that inhibits hepatic PCSK9 synthesis, in 482 adults with…”
    Get full text
    Journal Article
  4. 4

    Fibrin(ogen) in cardiovascular disease: an update by Koenig, Wolfgang

    Published in Thrombosis and haemostasis (01-04-2003)
    “…The notion that fibrinogen is strongly, consistently, and independently related to cardiovascular risk has been widely accepted. The evidence is based on…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Familial Hypercholesterolemia: Pitfalls and Challenges in Diagnosis and Treatment by Arnold, Natalie, Koenig, Wolfgang

    Published in Reviews in cardiovascular medicine (01-08-2023)
    “…Familial hypercholesterolemia (FH), a condition, which is characterized by a life-long exposure to markedly elevated low-density lipoprotein (LDL)…”
    Get full text
    Journal Article
  7. 7

    Cystatin C and Cardiovascular Risk by Taglieri, Nevio, Koenig, Wolfgang, Kaski, Juan Carlos

    Published in Clinical chemistry (Baltimore, Md.) (01-11-2009)
    “…Patients with chronic kidney disease (CKD) are at high risk for developing cardiovascular disease (CVD) and cardiovascular events. Cystatin C, a protease…”
    Get full text
    Journal Article
  8. 8

    Inclisiran and cardiovascular events: a patient-level analysis of phase III trials by Ray, Kausik K, Raal, Frederick J, Kallend, David G, Jaros, Mark J, Koenig, Wolfgang, Leiter, Lawrence A, Landmesser, Ulf, Schwartz, Gregory G, Lawrence, David, Friedman, Andrew, Garcia Conde, Lorena, Wright, R Scott

    Published in European heart journal (07-01-2023)
    “…Inclisiran, an siRNA administered twice-yearly, significantly reduced LDL cholesterol (LDL-C) in Phase III trials. Whether lowering LDL-C with inclisiran…”
    Get full text
    Journal Article
  9. 9

    Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study by Wallentin, Lars, Eriksson, Niclas, Olszowka, Maciej, Grammer, Tanja B, Hagström, Emil, Held, Claes, Kleber, Marcus E, Koenig, Wolfgang, März, Winfried, Stewart, Ralph A H, White, Harvey D, Åberg, Mikael, Siegbahn, Agneta

    Published in PLoS medicine (13-01-2021)
    “…Circulating biomarkers are associated with the development of coronary heart disease (CHD) and its complications by reflecting pathophysiological pathways…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Prospective Study of High-Sensitivity C-Reactive Protein as a Determinant of Mortality: Results from the MONICA/KORA Augsburg Cohort Study, 1984-1998 by Koenig, Wolfgang, Khuseyinova, Natalie, Baumert, Jens, Meisinger, Christa

    Published in Clinical chemistry (Baltimore, Md.) (01-02-2008)
    “…C-reactive protein (CRP), an exquisitely sensitive systemic marker of inflammation, has emerged as an independent predictor of cardiovascular diseases (CVD)…”
    Get full text
    Journal Article
  17. 17

    Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial by Kempf, Kerstin, Herder, Christian, Erlund, Iris, Kolb, Hubert, Martin, Stephan, Carstensen, Maren, Koenig, Wolfgang, Sundvall, Jouko, Bidel, Siamak, Kuha, Suvi, Jaakko, Tuomilehto

    Published in The American journal of clinical nutrition (01-04-2010)
    “…BACKGROUND: Coffee consumption is associated with a decreased risk of type 2 diabetes. Suggested mechanisms underlying the association have included…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Prevalence and Predictors of Subclinical Micronutrient Deficiency in German Older Adults: Results from the Population-Based KORA-Age Study by Conzade, Romy, Koenig, Wolfgang, Heier, Margit, Schneider, Andrea, Grill, Eva, Peters, Annette, Thorand, Barbara

    Published in Nutrients (23-11-2017)
    “…Subclinical micronutrient deficiency in older adults is associated with chronic age-related diseases and adverse functional outcomes. In Germany, the older…”
    Get full text
    Journal Article